logo-loader
viewFaron Pharmaceuticals Ltd

Faron Pharmaceuticals - Proactive One2One Investor Forum May 2019

Faron Pharmaceuticals Ltd’s (LON:FARN) chief executive Markku Jalkanen presents at the Proactive Investors One2One Investor Forum  in London May 2019.

For more information visit www.faron.com

Quick facts: Faron Pharmaceuticals Ltd

Price: 350 GBX

AIM:FARN
Market: AIM
Market Cap: £163.8 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Faron Pharmaceuticals Ltd named herein, including the promotion by the Company of Faron Pharmaceuticals Ltd in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Faron Pharmaceuticals CEO details £12mln fundraise and new WHO coronavirus trial

Faron Pharmaceuticals Oy (LON:FARN) (NASDAQFIRSTNORTH:FARON) CEO Dr Markku Jalkanen speaks to Proactive London's Andrew Scott after announcing they're donating interferon beta-1a drug supplies to treat 2,000 patients taking part in a globally crucial coronavirus (COVID-19) study. The World...

on 28/4/20

2 min read